Take the Quiz
Editorial · Direct Contact

Contact

Reach the GLP1 One Rx editorial team — corrections, methodology disputes, reader complaints, provider relations, press, and legal contacts at GLPONERX LLC.

Published by GLPONERX LLC Last updated October 16, 2026

How to reach the editorial team

GLP1 One Rx is operated by GLPONERX LLC, a Delaware limited liability company. We answer every email within five business days.

Editorial team[email protected]
Methodology & scoring disputes[email protected]
Reader complaints about a provider[email protected]
Provider relations[email protected]
Press inquiries[email protected]
Legal & privacy[email protected]

What we can and cannot help with

We can help with:

  • Reporting a factual error on a review or comparison page.
  • Submitting a verified reader complaint about a provider's pricing, billing, prescribing, or shipping practices.
  • Requesting coverage of a provider, peptide, or program not currently on the site.
  • Press, podcast, and conference appearance requests for our editorial team.
  • Privacy requests, GDPR/CCPA inquiries, and data deletion requests.

We cannot help with:

  • Clinical advice. We do not have a doctor-patient relationship with our readers. For medical advice, contact a licensed clinician.
  • Billing or prescription disputes with a provider. Contact the provider directly first; we can document the dispute for our review file after you have tried.
  • Refund processing for any provider. We are not party to any transaction between a reader and a provider.

Mailing address

For legal notices and physical correspondence:

GLPONERX LLC
Attn: Editorial Office
1209 Orange Street
Wilmington, DE 19801
United States

Submitting a tip or story idea

We welcome tips on pricing changes, provider personnel changes, FDA actions, state board actions, compounding pharmacy 483 observations, and reader-experience patterns. Tips can be submitted anonymously through [email protected]. We do not publish unverified tips; verified tips that lead to a published correction or new coverage page are acknowledged anonymously in the corrections log unless the reader requests otherwise.

Lead Medical Researcher
Dr. Sam Saberian
Doctor of Pharmacy; leads protocol research, peptide pharmacology, and provider evaluation.
Medical Reviewer
Alen A. Schwartz, MD
Board-certified physician; reviews clinical accuracy of every published page.
Editor
Julliana Edwards
Editorial standards, factual accuracy, and corrections workflow.

Primary sources

  1. FDA: Compounding and the FDA — questions and answers
  2. FDA: Registered outsourcing facilities (503B)